Compound 1329
Identifiers
- Canonical SMILES:
COc1cccc2[nH]cc(C(=O)C(=O)N3CCN(C[C@@H]3C)C(=O)c3ccccc3)c12
- IUPAC name:
1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-(4-methoxy-1H-indol-3-yl)ethane-1,2-dione
- InChi:
InChI=1S/C23H23N3O4/c1-15-14-25(22(28)16-7-4-3-5-8-16)11-12-26(15)23(29)21(27)17-13-24-18-9-6-10-19(30-2)20(17)18/h3-10,13,15,24H,11-12,14H2,1-2H3/t15-/m0/s1
- InChiKey:
YWHUPMDHHBIXPR-HNNXBMFYSA-N
External links
![]() 506331 |
![]() CHEMBL583905 |
![]() 442162 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 8.48 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 405.17 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 2.42 | |||
TPSA | 82.71 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7239 | BMS-488043 | DB05532 | |
0.6522 | Timcodar | DB12761 | |
0.6474 | Talmapimod | DB05412 | |
0.6349 | Melatonin | DB01065 | |
0.6028 | LY-517717 | DB05713 | |
0.6000 | N-acetylserotonin | DB04275 | |
0.5968 | Dipropyl-4-hydroxytryptamine | DB13990 | |
0.5923 | N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID | DB07952 | |
0.5794 | 5-Methoxy-N,N-diisopropyltryptamine | DB01441 | |
0.5778 | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | DB07953 | |
0.5763 | Varespladib | DB11909 | |
0.5679 | Piromelatine | DB12288 | |
0.5676 | Oxypertine | DB13403 | |
0.5667 | Varespladib methyl | DB05737 | |
0.5664 | N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide | DB08190 |